Evaluation of β-cell function in diabetic Taiwanese children using a 6-min glucagon test

European Journal of Pediatrics

Volumn 167, Issue 7, 2008, Pages 801-805

  Tung, Yi Ching ^a,b   Lee, Jing Sheng ^a,b   Tsai, Wen Yu ^a   Hsiao, Pei Hung ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

cell; C peptide; Glucagon test; Type 1 diabetes; Type 2 diabetes

Indexed keywords

C PEPTIDE; GLUCAGON; HEMOGLOBIN A1C;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; BODY MASS; CELL FUNCTION; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIET RESTRICTION; DIFFERENTIAL DIAGNOSIS; FEMALE; GLUCAGON BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PREPUBERTY; PRIORITY JOURNAL; PROVOCATION TEST; PUBERTY; RECEIVER OPERATING CHARACTERISTIC; TAIWAN;

ADOLESCENT; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; EVALUATION STUDIES AS TOPIC; FEMALE; GLUCAGON; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT; ISLETS OF LANGERHANS; MALE; ROC CURVE; TAIWAN;

EID: 44349194446     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-007-0594-9     Document Type: Article

References (24)

1. Alford FP, Henriksen JE, Rantzau C, Vaag A, Hew LF, Ward GM, Beck-Nielsen H (1998) Impact of family history of diabetes on the assessment of β-cell function. Metabolism 47:522-528
2. American Diabetes Association (2000) Type 2 diabetes in children and adolescents. Pediatrics 105:671-680
3. Arnqvist HJ, Littorin B, Nystrom L, Schersten B, Ostman J, Blohme G, Lithner F, Wibell L (1993) Difficulties in classifying diabetes at presentation in young adults. Diabetic Med 10:606-613
4. Ashcroft FM, Ashcroft SJH (1980) Glucoreceptor mechanisms and the control of insulin release and biosynthesis. Diabetologia 18:5-15
5. Ashcroft FM, Rorsman P (1989) Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 54:87-143
6. Berger B, Stenstrom G, Sundkvist G (2000) Random C-peptide in the classification of diabetes. Scand J Clin Lab Invest 60:687-694
7. Castillo MJ, Scheen AJ, Lefebvre PJ (1995) Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 80:393-399
8. Elder DA, Prigeon RL, Wadwa RP, Dolan LM, D'Alessio DA (2006) β-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults. J Clin Endocrinol Metab 91:185-191
9. Faber OK, Binder C (1977) C-peptide response to glucagon. A test for the residual β-cell function in diabetes mellitus. Diabetes 26:605-610
10. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36
11. Hother-Nielson O, Faber O, Sorensen NS, Beck-Nielsen H (1988) Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care 11:531-537
12. Kolendorf K, Thorsteinsson B, Billesbolle P, Poulsen S (1982) Correlation between the routine 6-min. C-peptide value and the AUC after I.V. glucagon injection in NIDDM patients. Horm metabol Res 14:675-676
13. Koskinen P, Viikari J, Irjala K, Kaihola HL, Seppala P (1985) C-peptide determination in the choice of treatment in diabetes mellitus. Scand J Clin Lab Invest 45:589-597
14. Madsbad S, Krarup T, McNair P, Christiansen C, Faber OK, Transbol I, Binder C (1981) Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 210:153-156
15. Maldonado M, Hampe CS, Gaur LK, D'Amico S, Iyer D, Hammerle LP, Bolgiano D, Rodriguez L, Rajan A, Lernmark A, Balasubramanyam A (2003) Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and β-cell function classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 88:5090-5098
16. McCulloch DK, Palmer JP (1991) The appropriate use of B-cell function testing in the preclinical period of type 1 diabetes. Diabetic Med 8:800-804
17. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI (2003) Mitochondrial dysfunction in the elderly : possible role in insulin resistance. Science 300:1140-1142
18. Poulsen S, Billesbolle P, Kolendorf K, Thorsteinsson B (1985) The C-peptide response to glucagon injection in IDDM and NIDDM patients. Horm Metabol Res 17:39-40
19. Salmos E, Marri G, Marks V (1965) Promotion of insulin secretion by glucagon. Lancet 2:415-416
20. Sakura H, Ashcroft SJH, Terauchi Y, Kadowaki T, Ashcroft FM (1998) Glucose modulation of ATP-sensitive K-currents in wild-type, homozygous and heterozygous glucokinase knock-out mice. Diabetologia 41:654-659
21. Taha D, Umpaichitra V, Banerji MA, Castells S (2006) Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance. J Pediatr Endocrinol Metab 19:135-142
22. The Expert Committee on the diagnosis and classification of diabetes mellitus (1997) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197
23. Wei JN, Sung FC, Lin CC, Lin RS, Chiang CC, Chuang LM (2003) National surveillance for type 2 diabetes mellitus in Taiwanese children. JAMA 290:1345-1350
24. Welborn TA, Webb PG, Bonser AM (1981) Basal C-peptide in the discrimination of type I from Type II Diabetes. Diabetes Care 4:616-619